Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

ClinicalTrials.gov ID: NCT00598442

Public ClinicalTrials.gov record NCT00598442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 10:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AFX01-13: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Correction of Anemia in Patients With Chronic Renal Failure (CRF) Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment

Study identification

NCT ID
NCT00598442
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Affymax
Industry
Enrollment
493 participants

Conditions and interventions

Interventions

  • peginesatide Drug
  • Darbepoetin alfa Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Jun 30, 2009
Completion
Nov 30, 2009
Last update posted
Feb 11, 2013

2007 – 2009

United States locations

U.S. sites
42
U.S. states
24
U.S. cities
41
Facility City State ZIP Site status
Research Facility Phoenix Arizona 85012
Research Facility Fayetteville Arkansas 72703
Research Facility Fountain Valley California 92708
Research Facility Fullerton California 92835
Research Facility Granada Hills California 91344
Research Facility Los Angeles California 90022
Research Facility San Diego California 92123
Research Facility Whittier California 90603
Research Facility Lauderdale Lakes Florida 33313
Research Facility Pembroke Pines Florida 33028
Research Facility Pinecrest Florida 33156
Research Facility Canton Georgia 30114
Research Facility Columbus Georgia 31904
Research Facility Marietta Georgia 30060
Research Facility Caldwell Idaho 83605
Research Facility Meridian Idaho 83642
Research Facility Chicago Illinois 60611
Research Facility Mishawaka Indiana 46545
Research Facility Ames Iowa 50010
Research Facility Baton Rouge Louisiana 70809
Research Facility Lafayette Louisiana 70506
Research Facility Rockville Maryland 20852
Research Facility Springfield Massachusetts 01107
Research Facility Detroit Michigan 48202
Research Facility Detroit Michigan 48236
Research Facility Flint Michigan 48504
Research Facility Petoskey Michigan 49770
Research Facility Troy Michigan 48098
Research Facility Washington Missouri 63090
Research Facility Flushing New York 11355
Research Facility Williamsville New York 14221
Research Facility Asheville North Carolina 28801
Research Facility Columbus Ohio 43210
Research Facility Bend Oregon 97701
Research Facility Arlington Texas 76015
Research Facility Houston Texas 77004
Research Facility San Antonio Texas 78229
Research Facility Burlington Vermont 05401
Research Facility Fairfax Virginia 22030
Research Facility Tacoma Washington 98405
Research Facility Morgantown West Virginia 26506
Research Facility Neenah Wisconsin 54956

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00598442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2013 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00598442 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →